E
CELU icon

Ergoteles’s Celularity CELU Stock Holding History

Ergoteles’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,710
Closed -$25.1K – 178
2023
Q2 		$25.1K Buy
+4,710
New +$30.2K ﹤0.01% 980

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ergoteles's CELU Position: Q3 2023 in Review

Ergoteles sold out of Celularity (CELU) in Q3 2023, closing a stake of 4,710 shares — an estimated $25.1K sold.

Ergoteles first reported a position in CELU in Q2 2023 and held it in 1 quarter. The position peaked at $25.1K in Q2 2023. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

  • Ergoteles reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 4,710 Celularity shares in Q3 2023, an estimated $25.1K.
  • Ergoteles first reported a position in Celularity in Q2 2023 and held it in 1 quarter.
  • Ergoteles's Celularity position peaked at $25.1K in Q2 2023.
  • 45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.